Codice QR

Apixaban Versus Aspirin to Reduce Cognitive Decline After Cryptogenic Stroke and Atrial Cardiopathy: ARCADIA‐Cognition Study

Background ARCADIA (Atrial Cardiopathy and Antithrombotic Drugs in Prevention After Cryptogenic Stroke), a secondary stroke prevention study comparing apixaban versus aspirin for cryptogenic stroke and biomarkers of atrial cardiopathy, ended prematurely for futility. In the ARCADIA‐Cognition study w...

Descrizione completa

Salvato in:
Autori principali: Ronald M. Lazar, George Howard, Michael T. Brewer, Christy Cassarly, Qi Pauls, Stephanie Kemp, David L. Tirschwell, Kevin N. Sheth, Max Wintermark, Hooman Kamel, W. T. Longstreth Jr, Mitchell S.V. Elkind, Joseph P. Broderick, Maarten G. Lansberg
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wiley 2025-09-01
Serie:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Soggetti:
Apixaban
aspirin
atrial cardiopathy
cognition
covert infarction
Accesso online:https://www.ahajournals.org/doi/10.1161/JAHA.125.042147
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi